Biop Medical raises $2.25M to advance development of mobile device to detect cervical cancer
The Series A financing round of $2.25 million will be used to move forward with the development of its point-of-care diagnostic tools for the accurate detection of epithelium cancers, with a primary focus on cervical cancer.